Overview: In October 2020 United States' Packaged Medicaments exports accounted up to $2.13B and imports accounted up to $6.73B, resulting in a negative trade balance of $4.6B. Between October 2019 and October 2020 the exports of United States' Packaged Medicaments have increased by $162M (8.24%) from $1.97B to $2.13B, while imports decreased by $-212M (-3.05%) from $6.94B to $6.73B.
Destinations: In October 2020 Packaged Medicaments exported mostly to China ($261M), Canada ($245M), Japan ($183M), Netherlands ($163M), and Belgium ($155M), and imported mostly from Ireland ($1.52B), Switzerland ($989M), Denmark ($725M), Germany ($713M), and India ($702M).
Growth: In October 2020, the increase in Packaged Medicaments's year-by-year exports was explained primarily by an increase in exports to China ($105M or 67.4%), Australia ($98.8M or 302%), and United Kingdom ($42.2M or 42.9%). In October 2020, the decrease in Packaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Switzerland ($-180M or -15.4%), Germany ($-169M or -19.2%), and Italy ($-168M or -36.2%).